Friday, May 27, 2022
High Yields Cannabis/Marijuana/ Weed News
  • Home
  • Cannabis Stocks
  • Cannabis Strains
  • Cannabis Laws
    • Marijuana Laws in All 50 States
    • International Marijuana Laws 2021
  • Product Reviews
  • Growing
  • Write for Us
No Result
View All Result
  • Home
  • Cannabis Stocks
  • Cannabis Strains
  • Cannabis Laws
    • Marijuana Laws in All 50 States
    • International Marijuana Laws 2021
  • Product Reviews
  • Growing
  • Write for Us
No Result
View All Result
High Yields
No Result
View All Result
Home Cannabis Stock Quotes & News

InterCure Announces Record Preliminary Third Quarter

Jeremy Vedder by Jeremy Vedder
October 25, 2021
in Cannabis Stock Quotes & News
0
InterCure Announces Record Preliminary Third Quarter

Achieved a number of firsts and records including:

Seventh consecutive quarter of double-digit revenue growth

Seventh consecutive quarter of high digit accelerated profitable growth

Record quarterly EBITDA

Commenced trading on NASDAQ in September

CEO purchased over CAD$3.7 million worth of shares on the open market

NEW YORK and TORONTO and HERZLIYA, Israel, Oct. 25, 2021 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) today announced preliminary unaudited revenue of CAD$24 million (NIS 61 million) for the third quarter of 2021, representing another record quarter of high sequential and year-over-year revenue growth.  All amounts are expressed in Canadian dollars ($) or New Israeli Shekels (NIS), unless otherwise noted.

Preliminary Third Quarter 2021 and Recent Highlights

  • Record revenue expected to be an estimated CAD$24 million (NIS 61 million), 3 times greater than Q3 2020 and up more than 36% compared to prior quarter sequentially;
  • Increased market share due to solid demand for Canndoc’s branded products and expansion of InterCure’s retail footprint;
  • Further increases in EBITDA during the third quarter;
  • Over $78 million in cash (more than NIS 200 million) as of September 30, 2021;
  • Commenced trading on NASDAQ in September under the symbol INCR; and
  • InterCure’s CEO purchased over 420,000 shares of the Company’s stock on the open market, valued at over $3.7 million.

The Company plans to file its full financial results for the third quarter of 2021 on Monday, November 15, 2021.

*Amounts shown are in CAD

Preliminary Third Quarter 2021 Results Commentary

READ ALSO

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

How to throw the cannabis wedding of your dreams

Revenue and same-store sales growth during the third quarter of 2021 reflects increased market share, growing demand for the Company’s branded products and expansion of its medical cannabis dispensing operations, including its ‘GIVOL’ pharmacy chain. Further increases in EBITDA realized during the quarter reflect InterCure’s execution success.

Legislation of adult-use cannabis and CBD products in Israel is expected to drive further domestic demand for the Company’s products. Complementing this, solid international demand for InterCure’s GMP-branded products and easing regulation in Israel for medical cannabis exportation is expected to support the Company’s global expansion in international target markets, including Europe.

With one of the strongest balance sheets in the industry, including over $78 million in cash (more than NIS 200 million) as of September 30, 2021, and a vertically integrated and scalable seed to sell model, the Company expects to lead market consolidation.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated “seed-to-sale” model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

To be added to InterCure’s email distribution list, please email InterCure@kcsa.com with “InterCure” in the subject.

Cautionary Note Regarding Preliminary Financial Estimates and Growth

The preliminary financial estimates and growth disclosure set forth above are estimates based on information currently available to the Company and based on judgments that the Company believes are reasonable. The Company’s financial closing procedures for the quarter ended September 30, 2021 are not yet complete and, as a result, its actual results may differ materially from these estimates. The preliminary estimates have been prepared by, and are the responsibility of, management. The Company’s independent registered public accounting firm, Somekh Chaikin (member firm of KPMG International), has not audited, reviewed compiled or performed any procedures with respect to the accompanying financial estimates and other data, and accordingly does not express an opinion or any other form of assurance with respect thereto. They should not be viewed as a substitute for the Company’s full interim audited financial statements prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, and are not necessarily indicative of the Company’s results for any future period.

Forward-Looking Statements

This press release may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to InterCure’s objectives plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that InterCure intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as “believes,” “hopes,” “may,” “anticipates,” “should,” “intends,” “plans,” “will,” “expects,” “estimates,” “projects,” “positioned,” “strategy” and similar expressions and are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate.. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Many factors could cause InterCure’s actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the following: the Company’s Q3 2021 revenue, the success of its global expansion plans, the expected annualized revenue for 2021, its continued growth, the expected operations, financial results business strategy, competitive strengths, goals and expansion and growth plans, expansion strategy to major markets worldwide and the impact of the COVID-19 pandemic. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond InterCure’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to: changes in general economic, business and political conditions, changes in applicable laws, the U.S. and Canadian regulatory landscapes and enforcement related to cannabis, changes in public opinion and perception of the cannabis industry, reliance on the expertise and judgment of senior management, as well as the factors discussed under the heading “Risk Factors” in Subversive Acquisition LP’s final long form prospectus dated March 15, 2021, which is available on SEDAR at www.sedar.com, and in other filings that InterCure has made and may make with the SEC in the future.. The forward-looking statements contained in this press release are made as of the date of this press release and reflect InterCure’s current views with respect to future events, and InterCure does not undertake and specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@canndoc-pharma.com

KCSA Strategic Communications
Investor and Media Relations
InterCure@kcsa.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/47e83a9e-7d3a-48af-9fd6-e109ae4d2c87

[Original Source]

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0

Related Posts

Fire & Flower and Hifyre announce proposed acquisition of PotGuide
Cannabis Stock Quotes & News

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

May 26, 2022
How to throw the cannabis wedding of your dreams
Cannabis Stock Quotes & News

How to throw the cannabis wedding of your dreams

May 26, 2022
Medical Marijuana, Inc. CEO Featured on Seeking Alpha’s CEO
Cannabis Stock Quotes & News

California cannabis companies brace for environmental law compliance

May 26, 2022
Aleafia Health Announces the Appointment of Mark J. Sandler
Cannabis Stock Quotes & News

California DCC debuts data tool showcasing access areas for cannabis businesses

May 26, 2022
Best Cannabis Seeds For Sale Online
Cannabis Stock Quotes & News

Cannabis consumption lounges coming to Grover Beach

May 26, 2022
Eaze launches first dispensaries in San Diego and Santa Ana
Cannabis Stock Quotes & News

Rubicon Organics Amends and Grants Stock Options

May 26, 2022
Next Post
10 Perfect Strains for a Netflix Bender This Winter

10 Perfect Strains for a Netflix Bender This Winter

  • Trending
  • Comments
  • Latest
Monthly Spotlight: The Best of Plain Jane CBD

Monthly Spotlight: The Best of Plain Jane CBD

April 8, 2022
The Ultimate Dr. Dabber Stella Vaporizer Review for 2022

The Ultimate Dr. Dabber Stella Vaporizer Review for 2022

April 19, 2022
volcano hybrid review 2022

The 2022 Volcano Hybrid Vaporizer Review: All You Need To Know

May 23, 2022
The Utillian 5 v3 Wax Pen Review for 2022

The Utillian 5 v3 Wax Pen Review for 2022

March 27, 2022

The 7 Best Smell-Proof Weed Bags To Keep Your Bud Stash Safe

April 27, 2022
The Best Synthetic Urine Kit to Pass Your Drug Test in 2022

The Best Synthetic Urine Kit to Pass Your Drug Test in 2022

May 23, 2022
The 10 Best Smell Proof Backpacks for Weed in 2022

The 10 Best Smell Proof Backpacks for Weed in 2022

May 5, 2022
Fire & Flower and Hifyre announce proposed acquisition of PotGuide

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

May 26, 2022
Former NFL Running Back Marshawn Lynch Launches Premium Blunt Brand

Former NFL Running Back Marshawn Lynch Launches Premium Blunt Brand

0
Major Marijuana Coalition Forms To Coordinate Legalization Push, But Some Key Advocacy Players Aren’t Involved

Major Marijuana Coalition Forms To Coordinate Legalization Push

0
MMJRecs - cannabis leaf

How Medical Marijuana Can Help Treat Sleep Disorders

0
Colorado Cannabis Sales Exceed $2 Billion in 2020

Colorado Cannabis Sales Exceed $2 Billion in 2020

0
Fire & Flower and Hifyre announce proposed acquisition of PotGuide

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

May 26, 2022
How to throw the cannabis wedding of your dreams

How to throw the cannabis wedding of your dreams

May 26, 2022
Medical Marijuana, Inc. CEO Featured on Seeking Alpha’s CEO

California cannabis companies brace for environmental law compliance

May 26, 2022
American Green, Inc.™ (OTC:ERBB) Earns Five Year Cannabis

Harborside Q1 Revenue Increases 14% Sequentially to $17.2 Million Ahead of Becoming StateHouse

May 26, 2022

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • March 2020

Categories

  • 1933 Industries
  • 4front Ventures
  • Acreage Holdings
  • Ascend Wellness
  • Ayr Wellness
  • Body & Mind
  • C21 Investments
  • Cannabis Stock Quotes & News
  • Cansortium Inc
  • Captor Capital
  • Ceres Acquisition Corp
  • Chalice Brands
  • Columbia Care
  • Cresco Labs
  • CuraLeaf
  • Gage Growth
  • Glass House Brands
  • Green Thumb Industries
  • Grown Rogue International
  • Harborside
  • Item 9 Labs
  • Jushi Holdings
  • Lowell Farms
  • MariMed
  • MedMen Enterprises
  • News
  • Next Green Wave
  • Planet 13
  • Plus Products
  • Product Reviews
  • Red White & Bloom
  • SLANG Worldwide
  • Sol Global Investments
  • TerrAscend
  • TILT Holdings
  • Trulieve
  • Verano Holdings
  • Vext Sciences
  • Vibe Growth

Recent Posts

  • New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs
  • How to throw the cannabis wedding of your dreams
  • California cannabis companies brace for environmental law compliance
  • Harborside Q1 Revenue Increases 14% Sequentially to $17.2 Million Ahead of Becoming StateHouse

QR Code

InterCure Announces Record Preliminary Third Quarter
No Result
View All Result
  • Homepages
    • Home Page 1
  • News

© 2021 High Yields